ReviewMolecular cancer therapeutics2012

Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm.

Sumanta Kumar Pal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.